Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan for improvement of microcirculation in essential hypertension
ChiCTR2300073602Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of azilsartan in essential hypertension (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Fundus microvascular density. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
azilsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2300073602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073602.